Pfizer (PFE) cash: $1.1B
Pfizer held $1.1B in cash and cash equivalents on Dec 31, 2025, up 9.5% from $1B a year earlier.
From Pfizer's filings with the SEC · Read the filing · PFE stock page
Pfizer cash by year
#467 of 4,171 US companies by cash · See the full ranking
| Year ended | Cash | Change |
|---|---|---|
| Dec 31, 2025 | $1.1B | +9% |
| Dec 31, 2024 | $1B | -63% |
| Dec 31, 2023 | $2.9B | +586% |
| Dec 31, 2022 | $416M | -79% |
| Dec 31, 2021 | $1.9B | – |
Cash of similar companies
Companies in the same industry as Pfizer, by SEC industry code, with the closest cash. Each name opens the same page for that company.
| Company | Cash, latest year | Year ended |
|---|---|---|
| Jazz Pharmaceuticals | $1.4B | Dec 31, 2025 |
| Viatris | $1.3B | Dec 31, 2025 |
| Biomarin Pharmaceutical | $1.3B | Dec 31, 2025 |
| Bausch Health Companies | $1.3B | Dec 31, 2025 |
| Pfizer | $1.1B | Dec 31, 2025 |
| PTC Therapeutics | $985M | Dec 31, 2025 |
| Dyne Therapeutics | $893M | Dec 31, 2025 |
Questions and answers
What is Pfizer's cash?
Pfizer held $1.1B in cash and cash equivalents on Dec 31, 2025, up 9.5% from $1B a year earlier.
Numbers as reported in Pfizer's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology